Clinical Trials Browser

Adenoviridae Infections, Virus Diseases, Epstein-Barr Virus Infections

NCT05101213 2025-10-14

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

Phase 1 Recruiting

30 enrolled

Other hematologic neoplasm

Adenoviridae Infections, Cytomegalovirus Infections, Hematologic Neoplasms

NCT06909110 2025-08-14

Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity

Phase 1/2 Recruiting

25 enrolled

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT04013802 2025-08-08

TETRAVI

Phase 1 Recruiting

47 enrolled

Adenoviridae Infections, Virus Diseases, Epstein-Barr Virus Infections

NCT06926894 2025-07-31

R-MVST Cells for Treatment of Viral Infections in Children and Young Adults

Phase 1 Recruiting

18 enrolled

Adenoviridae Infections, Cytomegalovirus Infections, Immunologic Deficiency Syndromes, Epstein-Barr Virus Infections

NCT04832607 2025-07-18

TRACE

Phase 3 Recruiting

149 enrolled

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT06027879 2025-06-25

Gamma Capture

Phase 1/2 Enrolling by invitation

25 enrolled

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT03475212 2025-05-11

ACES

Phase 1/2 Active not recruiting

52 enrolled

Primary Immunodeficiency Diseases, Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT03916510 2025-02-06

CEDAR

Phase 1 Completed

12 enrolled 13 charts

Gastrointestinal

Adenoviridae Infections, Rectal Neoplasms

NCT05183490 2024-12-30

R-MVST Cells for Treatment of Viral Infections

Phase 1 Recruiting

36 enrolled

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT06585527 2024-10-31

Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma

Phase 1 Recruiting

30 enrolled

CNS

Adenoviridae Infections, Glioblastoma, Glioma

NCT02555397 2024-10-10

Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate Cancer

Phase 1 Completed

15 enrolled 11 charts

Genitourinary

Adenoviridae Infections, Prostatic Neoplasms

NCT04374240 2021-11-03

AdUP

Phase 1 Completed

18 enrolled

Genitourinary

Adenoviridae Infections, Prostatic Neoplasms

NCT01535885 2021-10-25

ACE

Phase 1 Completed

25 enrolled

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT04739046 2021-03-17

An Exploratory Trial to Evaluate Efficacy and Safety for Combination Treatment of Adenovirus Double Suicide Gene Therapy

Phase 2 Unknown

12 enrolled

Gastrointestinal

Adenoviridae Infections, Pancreatic Neoplasms

NCT03159364 2019-09-19

Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections

Phase 1/2 Unknown

100 enrolled

Adenoviridae Infections, Cytomegalovirus Infections, Mycoses, Tuberculosis, Epstein-Barr Virus Infections

NCT02894944 2019-09-12

Theragene

Phase 1 Completed

9 enrolled

Gastrointestinal

Adenoviridae Infections, Pancreatic Neoplasms

NCT03029871 2019-08-13

NSCLC

Phase 1 Withdrawn

Thoracic

Adenoviridae Infections, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03190824 2019-04-16

Evaluate Efficacy, Immunological Response of Intratumoral/Intralesional Oncolytic Virus (OBP-301) in Metastatic Melanoma

Phase 2 Unknown

4 enrolled

Dermatologic

Adenoviridae Infections, Melanoma

NCT01864759 2017-08-29

Phase I Endovenous Administration of Oncolytic Adenovirus ICOVIR-5 in Patients With Advanced or Metastatic Melanoma

Phase 1 Completed

14 enrolled

Dermatologic

Adenoviridae Infections, Melanoma, Neoplasm Metastasis

NCT00711035 2016-04-26

CHALLAH

Phase 1/2 Completed

50 enrolled

Adenoviridae Infections, Epstein-Barr Virus Infections

NCT01070797 2014-09-04

VIRAGE

Phase 1 Completed

10 enrolled

Adenoviridae Infections, Cytomegalovirus Infections, Virus Diseases, Epstein-Barr Virus Infections

NCT00262327 2006-06-20

Safety and Efficacy of Adenoviral Endostatin in the Treatment of Advanced Solid Tumor

Phase 1 Unknown

20 enrolled

Adenoviridae Infections, Neoplasms

Clinical Trials

VSTs

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity

TETRAVI

R-MVST Cells for Treatment of Viral Infections in Children and Young Adults

TRACE

Gamma Capture

ACES

CEDAR

R-MVST Cells for Treatment of Viral Infections

Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma

Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate Cancer

AdUP

ACE

An Exploratory Trial to Evaluate Efficacy and Safety for Combination Treatment of Adenovirus Double Suicide Gene Therapy

Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections

Theragene

NSCLC

Evaluate Efficacy, Immunological Response of Intratumoral/Intralesional Oncolytic Virus (OBP-301) in Metastatic Melanoma

Phase I Endovenous Administration of Oncolytic Adenovirus ICOVIR-5 in Patients With Advanced or Metastatic Melanoma

CHALLAH

VIRAGE

Safety and Efficacy of Adenoviral Endostatin in the Treatment of Advanced Solid Tumor